NUC Approves Commencement of Doctor of Pharmacy and Speech Language Therapy Programmes at UNIMED, Ondo

NUC Approves Commencement of Doctor of Pharmacy and Speech Language Therapy Programmes at UNIMED, Ondo

The National Universities Commission (NUC) has considered and approved the establishment of the full time mode for Doctor of Pharmacy (Pharm. D.) and B.SLT. Speech Language Therapy programmes to be run by the University of Medical Sciences (UNIMED), Ondo.

 

These programmes shall commence with effect from 2024/2025 academic session, which begins on the 6th October, 2024. In a letter conveying the approval, with reference number NUC/AP/S33/VOL I/40 and signed by Abubakar M. Girei, Acting Director of Academic Planning, on behalf of the Executive Secretary,, the Commission enjoined the University “to provide adequate human and material resources for the development and growth of the programme”.

 

The Vice-Chancellor, Professor Adesegun Fatusi, in his reaction to the NUC approval, thanked the Commission for their prompt action after the resource verification visit and assured her of UNIMED’s unwavering commitment to making the programmes a huge success “I thank NUC for the confidence reposed in UNIMED, particularly with the dispatch with which the approval was given and I assure the Commission of our commitment to making the programmes an envy of all”.

 

E-SIGNED

 

Isaac Oluyi

PRO, UNIMED, Ondo.

23rd September, 2024

Related posts

Nigeria Becomes First Country To Use Meningitis Vaccine

Abisola

Ifon/Ilobu communal Clashes: Osun Govt sets up a 16 member Resolution Committee 

Abisola

OSCOED GOVERNING COUNCIL PANEL RECOMMENDS SUSPENSION OF PROVOST AFOLABI 

Abisola

Fed Poly Ede Rector Hails Osun NIESV, Partners On Development

Abisola

BRING HER IN: JDPMC Advocates Inclusive Women Political Participation In Osun

Abisola

Don’t worry about inflation, we’ll bring it down, Tinubu tells Nigerians

Abisola

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.